Ryan’s Quest, Michael’s Cause, and Pietro’s Fight have committed the $400,000 in seed capital toward developing DMD-813, which has shown promise in preclinical studies

source http://kianorshahmohammadi.com/post/158000558215

From http://dentaleconomicsus.blogspot.com/2017/03/startup-wins-400k-from-foundations-to.html

Advertisements